13F filing recap · Q3 2020

What did Matrix Asset Advisors buy in Q3 2020?

Reported stock-position changes between this filing and the previous one.

Stock value

$514.19M

Positions

Estimated turnover

17.6%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

PNWPinnacle West Capital Corp$5.90Mreported value+79.2K shares EDConsolidated Edison Inc$5.43Mreported value+69.8K shares LHXL3harris Technologies, Inc.$1.39Mreported value+8.2K shares SUBiShares Trust$920.0Kreported value+8.5K shares CLColgate-Palmolive Company$204.0Kreported value+2.6K shares

Increased positions

CVSCVS Health Corp$19.39Mreported value+6.1K shares+1.9%GILDGilead Sciences, Inc.$17.44Mreported value+23.7K shares+9.4%AAPLApple Inc.$13.86Mreported value+89.5K shares+296.9%KOCoca Cola Co$10.10Mreported value+33.5K shares

Reduced positions

MSFTMicrosoft Corporation$34.69Mreported value-12.7K shares-7.1%KKellanova$20.81Mreported value-12.8K shares-3.8%JPMJPMorgan Chase & Co$20.62Mreported value-15.5K shares-6.7%ABBVAbbvie Inc.$19.57Mreported value-38.3K shares

Exited positions

OPKOpko Health, Inc.$341.0Kprior reported value-100.0K shares-100.0%SRNESorrento Therapeutics Inc$314.0Kprior reported value-50.0K shares-100.0%